Interesting study, but I’m a little skeptical about the self-reported outcomes like better sleep and less stress. Since everyone knew which group they were in (because of the oil’s smell and feel), couldn’t the placebo effect play a big role here? How do we know the improvements weren’t just because people expected the oil to help, rather than it actually working? The objective measures (like gene stuff) seem solid, but the subjective ones feel shaky without blinding. Did the authors address this anywhere?
Fig. 2 is internally inconsistent with the stated ΔΔCt method….. If gene expression is expressed as fold change relative to control, control bars should be 1, but they are 9.91, 2.26, 2.83, and 3.39. Moreover, several fold changes are negative (MUC5AC: −1.94, −7.92; OCLN: −6.4, −10.28), which is impossible for a ΔΔCt-derived fold change (2−ΔΔCt2−ΔΔCt). Please clarify whether these are log2 ratios, mislabeled relative expression values, or erroneous.
Table 1 contains impossible/incorrect cell counts….. For control Family Type, Nuclear is 3 (9.1%) and Extended is 3, totaling 6, not the stated n=33; percentages are also missing/inconsistent in several rows. Please provide a corrected Table 1 with row totals matching group n.
Table 2 and the abstract/results disagree on nasal pH and sleep outcomes….. The abstract reports pH Δ=−0.16, p=0.01 for sesame only; Results report p=0.00 for both sesame and Anu oils; Table 2 omits the control/group-difference/CI for pH and only gives a sleep group difference for sesame. Please reconcile and report all between-group estimates with CIs and exact p-values.
Allocation concealment was not feasible due to color and odor confuses concealment with blinding….. Envelope allocation can conceal allocation before assignment; color/odor affect blinding after assignment. Please correct this methodological statement and clarify what was concealed versus blinded.
The causal interpretation of sleep improvement is not supported in an open-label trial with no nasal placebo…. Given distinct odor/local sensation and subjective PSQI, how do you exclude expectancy/attention effects? Also, assure safety is overstated from nonsignificant cytokine changes and no AE table in a 99-person pilot; please provide AE data by group and temper safety/efficacy claims.